Expression of EpCAM and prognosis in early-stage glottic cancer treated by radiotherapy (original ) (raw )Markers of Epithelial to Mesenchymal Transition in Association with Survival in Head and Neck Squamous Cell Carcinoma (HNSCC)
Raneem Hammouz
PLoS ONE, 2014
View PDFchevron_right
Expression of cell adhesion molecules in laryngeal carcinoma – preliminary analysis
Iwona Lewy-Trenda
Współczesna Onkologia, 2014
View PDFchevron_right
EpCAM expression in squamous cell carcinoma of the oral cavity: Frequency and relationship to clinicopathologic features
Stefan Hosch , Robert Gassner
Oral Oncology, 2008
View PDFchevron_right
Cancer-Related Signals of Epithelial Cell Adhesion Molecule (EpCAM): Review
Sheren Ahmed
2020
View PDFchevron_right
Molecular biomarkers and site of first recurrence after radiotherapy for head and neck cancer
George Wilson
European Journal of Cancer, 2004
View PDFchevron_right
Role of EGFR as prognostic factor in head and neck cancer patients treated with surgery and postoperative radiotherapy: proposal of a new approach behind the EGFR overexpression
Gioacchino Giugliano
Medical oncology (Northwood, London, England), 2017
View PDFchevron_right
Laryngeal carcinoma prognosis after postoperative radiotherapy correlates with CD105 expression, but not with angiogenin or EGFR expression
Haralabos Koussis
European Archives of Oto-Rhino-Laryngology, 2011
View PDFchevron_right
Association of epidermal growth factor receptor protein expression with histopathological and clinical parameters in carcinoma of the larynx
Amein Al-Ali
Translational Cancer Research
View PDFchevron_right
Quantitative Determination of Nuclear and Cytoplasmic Epidermal Growth Factor Receptor Expression in Oropharyngeal Squamous Cell Cancer by Using Automated Quantitative Analysis
Barbara Burtness
Clinical Cancer Research, 2005
View PDFchevron_right
Prognostic factors in head and neck cancer
Mwm Van Den Brekel
European Journal of Cancer, 2002
View PDFchevron_right
Adhesion Molecules as Prognostic Factors in Nasopharyngeal Carcinoma
Mark Delacure
The Laryngoscope, 2001
View PDFchevron_right
Effects of EGFR, CK19, CK20 and Survinin Gene Expression on Radiotherapy Results in Patients with Locally Advanced Head and Neck Cancer
Berrin Tunca
Asian Pacific journal of cancer prevention : APJCP, 2015
View PDFchevron_right
Molecular markers of response and resistance to EGFR inhibitors in head and neck cancers
Carol Box
Frontiers in Bioscience, 2013
View PDFchevron_right
Correlation between egfr expression and accelerated proliferation during radiotherapy of head and neck squamous cell carcinoma
Giovanni Storto , Alba Fiorentino
Radiation Oncology, 2012
View PDFchevron_right
Integrating Epidermal Growth Factor Receptor Assay With Clinical Parameters Improves Risk Classification for Relapse and Survival in Head-and-Neck Squamous Cell Carcinoma
Andy Trotti
International Journal of Radiation Oncology*Biology*Physics, 2011
View PDFchevron_right
Local Recurrence in Head and Neck Cancer Relationship to Radiation Resistance and Signal Transduction
Gillies McKenna
Clinical Cancer Research an Official Journal of the American Association For Cancer Research, 2002
View PDFchevron_right
Response to Therapy and Outcomes In Oropharyngeal Cancer Are Associated With Biomarkers Including Human Papillomavirus, Epidermal Growth Factor Receptor, …
Avraham Eisbruch
International Journal of …, 2007
View PDFchevron_right
WRAP53β, survivin and p16INK4a expression as potential predictors of radiotherapy/chemoradiotherapy response in T2N0-T3N0 glottic laryngeal cancer
Björn Palmgren
Oncology Reports
View PDFchevron_right
Epidermal growth factor receptor expression in primary laryngeal cancer: an independent prognostic factor of neck node relapse
Jacopo Galli
International journal of cancer. Journal international du cancer, 1999
View PDFchevron_right
Immunohistochemical Expression of Cortactin and Focal Adhesion Kinase Predicts Recurrence Risk and Laryngeal Cancer Risk Beyond Histological Grading
Isabel Vilaseca
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2018
View PDFchevron_right
Tumor-specific glycosylation of the carcinoma-associated epithelial cell adhesion molecule EpCAM in head and neck carcinomas
Barbara Wollenberg , Olivier Gires
Cancer Letters, 2003
View PDFchevron_right
Cytoplasmic accumulation of activated leukocyte cell adhesion molecule is a predictor of disease progression and reduced survival in oral cancer patients
Ajay Matta , Jatinder Kaur
International Journal of Cancer, 2009
View PDFchevron_right
ERCC1 is a prognostic biomarker in locally advanced head and neck cancer: Results from a randomised, phase II trial
Upendra Parvathaneni
2013
View PDFchevron_right
Radioresistant head and neck squamous cell carcinoma cells: Intracellular signaling, putative biomarkers for tumor recurrences and possible therapeutic targets
Peter Lukas
Radiotherapy and Oncology, 2011
View PDFchevron_right
Prognostic value of some tumor markers in unresectable stage IV oropharyngeal carcinoma patients treated with concomitant radiochemotherapy
Nina Gale
Radiology and Oncology, 2015
View PDFchevron_right
The prognostic value of epidermal growth factor receptor is related to tumor differentiation and the overall treatment time of radiotherapy in squamous cell carcinomas of the head and neck
Jesper Eriksen
International Journal of Radiation Oncology*Biology*Physics, 2004
View PDFchevron_right